Clearfield (CLFD) director receives 2,544-share stock grant award

Rhea-AI Filing Summary

Clearfield, Inc. director Carol Ann Wirsbinski reported an award of 2,544 shares of common stock. The shares were acquired at a stated price of $0.00 per share as a grant, not an open-market purchase, bringing her directly held total to 9,631 shares.

According to the filing, restrictions on this restricted stock lapse on the first business day prior to Clearfield’s 2027 Annual Meeting of Shareholders, meaning the shares will remain subject to vesting conditions until that time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wirsbinski Carol Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,544	$0.00	--

Holdings After Transaction: Common Stock — 9,631 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wirsbinski Carol Ann

(Last) (First) (Middle)

7050 WINNETKA AVE. N., STE. 100

(Street)

BROOKLYN PARK MN 55428

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clearfield, Inc. [ CLFD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	02/27/2026		A		2,544	A	$0	9,631	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restrictions on Restricted Stock lapse the first business day prior to the 2027 Annual Meeting of Shareholders.

	Darrell Hammond by Power of Attorney for Carol A Wirsbinski	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Clearfield (CLFD) director Carol Ann Wirsbinski report on this Form 4?

She reported receiving an award of 2,544 shares of Clearfield common stock. The filing identifies this as a grant or award acquisition, not an open-market trade, and shows her directly held total rising to 9,631 shares after the transaction.

When do restrictions on the new Clearfield (CLFD) restricted shares lapse?

Restrictions on the restricted stock lapse the first business day prior to Clearfield’s 2027 Annual Meeting of Shareholders. Until that date, the granted shares remain subject to vesting conditions as described in the Form 4 footnote.

What type of transaction is reported for Clearfield (CLFD) on this Form 4?

The Form 4 reports a grant or award acquisition of common stock, coded as an “A” transaction. This indicates an equity award to the director rather than a market purchase or sale of existing Clearfield shares.

How many Clearfield (CLFD) shares does the director own after this transaction?

After receiving the 2,544-share award, the Form 4 states that Carol Ann Wirsbinski directly owns 9,631 shares of Clearfield common stock. This figure reflects her total direct holdings immediately following the reported grant.

Did the Clearfield (CLFD) director pay cash for the 2,544 awarded shares?

No cash payment is indicated for the award; the transaction price per share is reported as 0.0000. This supports that the shares were granted as compensation rather than purchased in the open market.